Clinical Trial Update: Effect of Chronic Incretin-based Therapy in Cystic Fibrosis [NA]

View source ↗

Summary

A completed clinical trial evaluating chronic incretin-based therapy in cystic fibrosis with pancreatic insufficiency; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pancreatic Insufficiency

Snippet

Sponsor: University of Pennsylvania | Conditions: Cystic Fibrosis, Pancreatic Insufficiency | NA | Status: COMPLETED | Results posted: 2022-02-09